# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Aspira Women's Health Inc. ("Aspira") (NASDAQ:AWH), a bio-analytical based women's health company focused on th...
Alliance Global Partners analyst Ben Haynor maintains Aspira Womens Health (NASDAQ:AWH) with a Buy and lowers the price targ...
Aspira Womens Health (NASDAQ:AWH) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $...
- SEC Filing
Preliminary OvaWatch® volume during Q2 2024 grew 24% over the prior quarter to 1,307 units Preliminary OvaSuiteSM volume during...
The company announced it has entered into a securities purchase agreement dated June 30, 2024 with certain existing accredited ...
Monthly OvaSuiteSM product volume grew by more than 26% in May compared to January Reimbursement momentum continued with expand...
Aspira Womens Health (NASDAQ:AWH) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of...